Abstract This study explores the potential of Lacticaseibacillus rhamnosus LRa05 as a novel probiotic treatment for Candidal vaginitis. Isolated from fecal samples, LRa05 demonstrates superior antagonistic activity against Candida albicans, surpassing commercially available strains LGG, RC-14, and GR-1. Through in vitro and in vivo experiments, LRa05 significantly reduces...